Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, Spyckerelle C, Pariente B, Peyrin-Biroulet L, Turck D, Gower-Rousseau C; Epimad Group.

Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.228. [Epub ahead of print]

PMID:
28809388
2.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group.

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
3.

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.

Hochart A, Gower-Rousseau C, Sarter H, Fumery M, Ley D, Spyckerelle C, Peyrin-Biroulet L, Laberenne JE, Vasseur F, Savoye G, Turck D; Epimad Group.

Gut. 2016 Aug 3. pii: gutjnl-2016-311970. doi: 10.1136/gutjnl-2016-311970. [Epub ahead of print]

PMID:
27489240
4.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

5.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
6.

Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake.

Charpignon C, Lesgourgues B, Pariente A, Nahon S, Pelaquier A, Gatineau-Sailliant G, Roucayrol AM, Courillon-Mallet A; Group de l'Observatoire National des Ulcères de l'Association Nationale des HépatoGastroentérologues des Hôpitaux Généraux (ANGH).

Aliment Pharmacol Ther. 2013 Oct;38(8):946-54. doi: 10.1111/apt.12465. Epub 2013 Aug 27.

7.

A French national survey on the use of antibiotic prophylaxis in cirrhotic patients.

Thevenot T, Degand T, Grelat N, Elkrief L, Christol C, Moreau R, Henrion J, Cadranel JF, Sheppard F, Bureau C, di Martino V, Pauwels A; National Association of General Hospital Hepatogastroenterologists.

Liver Int. 2013 Mar;33(3):389-97. doi: 10.1111/liv.12093. Epub 2013 Jan 10.

PMID:
23302021
8.

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study.

Nahon S, Hagège H, Latrive JP, Rosa I, Nalet B, Bour B, Faroux R, Gower P, Arpurt JP, Denis J, Henrion J, Rémy AJ, Pariente A; Groupe des Hémorragies Digestives Hautes de l’ANGH.

Endoscopy. 2012 Nov;44(11):998-1008. doi: 10.1055/s-0032-1310006. Epub 2012 Oct 29.

PMID:
23108771
9.

Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patients.

Zeitoun JD, Rosa-Hézode I, Chryssostalis A, Nalet B, Bour B, Arpurt JP, Denis J, Nahon S, Pariente A, Hagège H; Groupe des Hémorragies Digestives Hautes de l’ANGH.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):227-34. doi: 10.1016/j.clinre.2011.11.008. Epub 2012 Feb 3.

PMID:
22306054
10.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group.

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
11.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group.

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
12.

[An unusual mastocytosis...].

Bafort D, Sempoux C, Bohon P, Theate I, Jouret-Mourin A.

Ann Pathol. 2009 Oct;29(5):440-2. doi: 10.1016/j.annpat.2009.09.002. French. No abstract available.

PMID:
20004852
13.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group.

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
14.

[Hypersensitivity interstitial pneumopathy and ulcero-hemorrhagic rectocolitis: role of methotrexate].

Bohon P, Dugernier T, Debongnie JC, Pirenne B.

Acta Gastroenterol Belg. 1993 Sep-Dec;56(5-6):352-7. Review. French.

PMID:
8140851

Supplemental Content

Loading ...
Support Center